BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 300542)

  • 21. Pharmacokinetics of ofloxacin. An overview.
    Flor S
    Am J Med; 1989 Dec; 87(6C):24S-30S. PubMed ID: 2603892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics of oral prazepam].
    Kölle EU
    Fortschr Med; 1981 Jun; 99(22):874-9. PubMed ID: 6790396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population Pharmacokinetics of High-Dose Oxazepam in Alcohol-Dependent Patients: Is There a Risk of Accumulation?
    Imbert B; Marsot A; Liachenko N; Simon N
    Ther Drug Monit; 2016 Apr; 38(2):253-8. PubMed ID: 26580099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.
    Dagrosa EE; Verho M; Malerczyk V; de Looze S; Hajdú P; Toyodera K
    Clin Ther; 1986; 8(6):632-45. PubMed ID: 3466701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of oxazepam in patients on maintenance hemodialysis.
    Ochs HR; Greenblatt DJ; Klehr U
    Klin Wochenschr; 1984 Aug; 62(16):765-7. PubMed ID: 6482312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple-dose kinetics and dialyzability of oxazepam in renal insufficiency.
    Greenblatt DJ; Murray TG; Audet PR; Locniskar A; Koepke HH; Walker BR
    Nephron; 1983; 34(4):234-8. PubMed ID: 6877459
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical pharmacokinetics of oxazepam and lorazepam.
    Greenblatt DJ
    Clin Pharmacokinet; 1981; 6(2):89-105. PubMed ID: 6111408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal disposition of oxazepam in acute viral hepatitis and cirrhosis.
    Shull HJ; Wilkinson GR; Johnson R; Schenker S
    Ann Intern Med; 1976 Apr; 84(4):420-5. PubMed ID: 769632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single dose pharmacokinetics and pharmacodynamics of oral oxazepam in very elderly institutionalised subjects.
    Sonne J; Loft S; Døssing M; Boesgaard S; Andreasen F
    Br J Clin Pharmacol; 1991 Jun; 31(6):719-22. PubMed ID: 1867967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two benzodiazepines with differing accumulation: behavioral changes during and after 3 weeks of dosing.
    Ghoneim MM; Hinrichs JV; Mewaldt SP
    Clin Pharmacol Ther; 1986 May; 39(5):491-500. PubMed ID: 3698458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of flumazenil-precipitated abstinence on the pharmacokinetics of chronic oxazepam in dogs.
    Wala EP; Sloan JW; Martin WR; Pruitt TA
    Pharmacol Biochem Behav; 1990 Feb; 35(2):347-50. PubMed ID: 2108448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disposition of oxazepam in relation to age, sex, and cigarette smoking.
    Ochs HR; Greenblatt DJ; Otten H
    Klin Wochenschr; 1981 Aug; 59(16):899-903. PubMed ID: 7278081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long v short half-life benzodiazepines in the elderly. Kinetics and clinical effects of diazepam and oxazepam.
    Salzman C; Shader RI; Greenblatt DJ; Harmatz JS
    Arch Gen Psychiatry; 1983 Mar; 40(3):293-7. PubMed ID: 6830408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucuronidation of oxazepam is not spared in patients with hepatic encephalopathy.
    Sonne J; Andreasen PB; Loft S; Døssing M; Andreasen F
    Hepatology; 1990 Jun; 11(6):951-6. PubMed ID: 2365292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal disease, age, and oxazepam kinetics.
    Murray TG; Chiang ST; Koepke HH; Walker BR
    Clin Pharmacol Ther; 1981 Dec; 30(6):805-9. PubMed ID: 7307429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excretion of oxazepam in breast milk.
    Wretlind M
    Eur J Clin Pharmacol; 1987; 33(2):209-10. PubMed ID: 3691611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of diflunisal on the pharmacokinetics of oxazepam.
    van Hecken AM; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Br J Clin Pharmacol; 1985 Sep; 20(3):225-34. PubMed ID: 4041343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption and disposition including enterohepatic circulation of (14C) roquinimex after oral administration to healthy volunteers.
    Strandgården K; Höglund P; Grönquist L; Svensson L; Gunnarsson PO
    Biopharm Drug Dispos; 2000 Mar; 21(2):53-67. PubMed ID: 11100907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis.
    Singlas E; Taburet AM; Borsa Lebas F; Parent de Curzon O; Sobel A; Chauveau P; Viron B; al Khayat R; Poignet JL; Mignon F
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1519-24. PubMed ID: 1510449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.